AHA GUIDELINES Bundle (free trial)

High Blood Pressure - Merck Supported

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1539869

Contents of this Issue

Navigation

Page 36 of 87

37 1 Initiate antihypertensive medications to lower BP and reduce CVD risk if average SBP ≥130 mm Hg or DBP ≥80 mm Hg for secondary prevention of CVD 1 Initiate antihypertensive medications to lower BP and reduce CVD risk if average SBP ≥130 mm Hg or DBP ≥80 mm Hg for primary prevention of CVD YES YES 1 Initiate antihypertensive medications to lower BP and reduce CVD risk for primary or secondary prevention of CVD YES * In older adults who may be frail or have a limited life expectancy, a clinician-patient assessment of potential benefits and harms of BP lowering should be pursued to align care with patient goals. † Increased short-term or 10-year risk is defined as a 10-year predicted risk for CVD events of ≥7.5% using PREVENT. CHD, coronary heart disease; HF, heart failure; and PREVENT, Predicting Risk of cardiovascular EVENTs.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - High Blood Pressure - Merck Supported